Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 2
2016 2
2019 1
2020 2
2021 1
2022 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
Gargiulo L, Ibba L, Malagoli P, Burroni AG, Chiricozzi A, Dapavo P, Ferrucci SM, Gola M, Napolitano M, Ortoncelli M, Rossi MT, Sciarrone C, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: burroni ag. Dermatol Ther (Heidelb). 2024 Apr;14(4):919-932. doi: 10.1007/s13555-024-01135-x. Epub 2024 Mar 21. Dermatol Ther (Heidelb). 2024. PMID: 38509380 Free PMC article.
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.
Gargiulo L, Ibba L, Piscazzi F, Amoruso F, Balato A, Barei F, Bertello M, Burroni AG, Caccavale S, Ferrucci SM, Foti C, Gaiani FM, Girolomoni G, Malagoli P, Marzano AV, Maurelli M, Napolitano M, Nettis E, Ortoncelli M, Patruno C, Pezzolo E, Ribero S, Romita P, Rossi MT, Zaza I, Guanti MB, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: burroni ag. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):e743-e746. doi: 10.1111/jdv.19862. Epub 2024 Feb 8. J Eur Acad Dermatol Venereol. 2024. PMID: 38329235 No abstract available.
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, Barei F, Burroni AG, Caccavale S, Calzavara-Pinton P, Esposito M, Fargnoli MC, Ferrucci SM, Foti C, Girolomoni G, Gola M, Guanti MB, Gurioli C, Magliulo M, Maurelli M, Morrone P, Musumeci ML, Napolitano M, Ortoncelli M, Patruno C, Piraccini BM, Pezzolo E, Ribero S, Rossi M, Savoia P, Sciarrone C, Tirone B, Vaccino M, Veronese F, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: burroni ag. J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10. J Dermatolog Treat. 2024. PMID: 39389612 Free article.
Ocular allergies: a psychodynamic approach.
Burroni AG, Maio M. Burroni AG, et al. Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):461-5. doi: 10.1097/ACI.0b013e32830f1dad. Curr Opin Allergy Clin Immunol. 2008. PMID: 18769202 Review.
Markers of microbial exposure lower the incidence of atopic dermatitis.
Chatenoud L, Bertuccio P, Turati F, Galeone C, Naldi L, Chatenoud L, La Vecchia C, Bach JF; HYGIENE Study Group. Chatenoud L, et al. Allergy. 2020 Jan;75(1):104-115. doi: 10.1111/all.13990. Epub 2019 Aug 12. Allergy. 2020. PMID: 31321780 Free article.
12 results